| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |